Epilepsy, depression and antidepressant drugs

Area of Science:

• Neuroscience
• Psychiatry
• Clinical Neurology

Background:

• Depression is a significant management challenge in epilepsy patients.
• The interplay of biological, psychological, and social factors contributes to comorbid depression in epilepsy.

Purpose of the Study:

• To review current knowledge on the prevalence and neurobiological causes of interictal depression in epilepsy.
• To provide an overview of recent concepts in depression management for epilepsy patients.
• To discuss antidepressant pharmacotherapy, considering seizure association and drug interactions.

Main Methods:

• Review of current literature on epilepsy and comorbid depression.
• Focus on neurobiological factors, neuroimaging, and neurochemical techniques.
• Analysis of recent antidepressant classes and their impact on seizure activity.

Main Results:

• Interictal depression in epilepsy is influenced by multiple interacting factors.
• Neurobiological underpinnings are a key focus in understanding the comorbidity.
• New antidepressant options require careful consideration regarding seizure risk and interactions.

Conclusions:

• Revisiting the topic of epilepsy and depression is timely due to new research approaches and treatments.
• Effective management requires a comprehensive understanding of neurobiological, psychological, and social aspects.
• Pharmacological treatment necessitates careful selection of antidepressants to minimize seizure risk and drug interactions.